Cargando…
Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279420/ https://www.ncbi.nlm.nih.gov/pubmed/35831276 http://dx.doi.org/10.1038/s41392-022-01077-w |
| _version_ | 1784746393939738624 |
|---|---|
| author | Liu, Zhichao Liu, Jun Li, Zhigang |
| author_facet | Liu, Zhichao Liu, Jun Li, Zhigang |
| author_sort | Liu, Zhichao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9279420 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92794202022-07-15 Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations Liu, Zhichao Liu, Jun Li, Zhigang Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2022-07-13 /pmc/articles/PMC9279420/ /pubmed/35831276 http://dx.doi.org/10.1038/s41392-022-01077-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Research Highlight Liu, Zhichao Liu, Jun Li, Zhigang Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations |
| title | Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations |
| title_full | Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations |
| title_fullStr | Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations |
| title_full_unstemmed | Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations |
| title_short | Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations |
| title_sort | chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279420/ https://www.ncbi.nlm.nih.gov/pubmed/35831276 http://dx.doi.org/10.1038/s41392-022-01077-w |
| work_keys_str_mv | AT liuzhichao chemoimmunotherapyinadvancedesophagealsquamouscellcarcinomaoptimizingchemotherapyregimensforimmunotherapycombinations AT liujun chemoimmunotherapyinadvancedesophagealsquamouscellcarcinomaoptimizingchemotherapyregimensforimmunotherapycombinations AT lizhigang chemoimmunotherapyinadvancedesophagealsquamouscellcarcinomaoptimizingchemotherapyregimensforimmunotherapycombinations |